Clorox (NYSE: CLX ) is expected to report Q3 earnings around May 1. Here's what Wall Street wants to see:
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Clorox's revenues will grow 2.5% and EPS will grow 3.9%.
The average estimate for revenue is $1.44 billion. On the bottom line, the average EPS estimate is $1.06.
Last quarter, Clorox chalked up revenue of $1.33 billion. GAAP reported sales were 8.5% higher than the prior-year quarter's $1.22 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, EPS came in at $0.93. GAAP EPS of $0.93 for Q2 were 18% higher than the prior-year quarter's $0.79 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 42.5%, 100 basis points better than the prior-year quarter. Operating margin was 16.0%, 130 basis points better than the prior-year quarter. Net margin was 9.3%, 70 basis points better than the prior-year quarter.
The full year's average estimate for revenue is $5.69 billion. The average EPS estimate is $4.34.
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 850 members out of 887 rating the stock outperform, and 37 members rating it underperform. Among 306 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 302 give Clorox a green thumbs-up, and four give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Clorox is hold, with an average price target of $75.57.
Can your portfolio provide you with enough income to last through retirement? You'll need more than Clorox. Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks." Click here for instant access to this free report.
- Add Clorox to My Watchlist.